These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 10873744

  • 21. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
    Rubinchik S, Wang D, Yu H, Fan F, Luo M, Norris JS, Dong JY.
    Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells.
    Shi CX, Long MA, Liu L, Graham FL, Gauldie J, Hitt MM.
    Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460
    [Abstract] [Full Text] [Related]

  • 24. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.
    Yoshida Y, Hamada H.
    Biochem Biophys Res Commun; 1997 Jan 13; 230(2):426-30. PubMed ID: 9016796
    [Abstract] [Full Text] [Related]

  • 25. Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors.
    Qu Z, Thottassery JV, Van Ginkel S, Manuvakhova M, Westbrook L, Roland-Lazenby C, Hays S, Kern FG.
    Gene; 2004 Feb 18; 327(1):61-73. PubMed ID: 14960361
    [Abstract] [Full Text] [Related]

  • 26. Transcriptional inactivation of amphotropic murine leukemia virus replication in human cells.
    Ploss M, Berdel B, Heber R, Reuss FU.
    J Med Virol; 2003 Feb 18; 69(2):267-72. PubMed ID: 12683417
    [Abstract] [Full Text] [Related]

  • 27. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B.
    J Gene Med; 2005 Jun 18; 7(6):818-34. PubMed ID: 15693055
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Transgene stability for three replication-competent murine leukemia virus vectors.
    Duch M, Carrasco ML, Jespersen T, Hansen BD, Pedersen FS.
    Gene; 2004 Mar 31; 329():61-9. PubMed ID: 15033529
    [Abstract] [Full Text] [Related]

  • 32. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
    Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R, Baum C, Bohne J.
    Gene Ther; 2006 Nov 31; 13(21):1524-33. PubMed ID: 16763662
    [Abstract] [Full Text] [Related]

  • 33. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
    Kung SK, An DS, Chen IS.
    J Virol; 2000 Apr 31; 74(8):3668-81. PubMed ID: 10729143
    [Abstract] [Full Text] [Related]

  • 34. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Lillehammer T, Tveito S, Engesaeter BO, Fodstad O, Maelandsmo GM, Engebraaten O.
    Cancer Gene Ther; 2005 Nov 31; 12(11):864-72. PubMed ID: 15891771
    [Abstract] [Full Text] [Related]

  • 35. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
    Higashimoto T, Urbinati F, Perumbeti A, Jiang G, Zarzuela A, Chang LJ, Kohn DB, Malik P.
    Gene Ther; 2007 Sep 31; 14(17):1298-304. PubMed ID: 17597793
    [Abstract] [Full Text] [Related]

  • 36. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C, Pierreux C, Adam E, Lemaigre F, Rousseau GG, Calomme C, Van Lint C, Christophe D, Kerkhofs P, Burny A, Kettmann R, Willems L.
    J Virol; 2001 Aug 31; 75(15):6977-88. PubMed ID: 11435578
    [Abstract] [Full Text] [Related]

  • 37. Genetic screens in mammalian cells by enhanced retroviral mutagens.
    Liu D, Yang X, Yang D, Songyang Z.
    Oncogene; 2000 Dec 07; 19(52):5964-72. PubMed ID: 11146547
    [Abstract] [Full Text] [Related]

  • 38. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S, Lee K, Kim MD, Kang S, Joo CW, Kim JM, Kim SH, Yu SS, Kim S.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1017-22. PubMed ID: 16574062
    [Abstract] [Full Text] [Related]

  • 39. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R, Glaser S, Sandra O, Martens UM, Klingmüller U.
    Gene Ther; 2002 Apr 19; 9(8):477-87. PubMed ID: 11948372
    [Abstract] [Full Text] [Related]

  • 40. Lentiviral vectors: regulated gene expression.
    Kafri T, van Praag H, Gage FH, Verma IM.
    Mol Ther; 2000 Jun 19; 1(6):516-21. PubMed ID: 10933976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.